Radiopharmaceuticals Market Size, Share, Growth Analysis, By Type(Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals), By Application(Diagnostic Applications, SPECT Applications), By Procedural Volume Assessment(Diagnostic Procedures, Therapeutic Procedures), By Source(Nuclear Reactors, Cyclotrons), By End User(Hospitals, Ambulatory Surgical Centers), By Regional(North America, Europe) - Industry Forecast 2024-2031

Segmentation Analysis:

The Radiopharmaceuticals Market is segmented by Type, Application, Procedural Volume Assessment, Source, End User, Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

Radiopharmaceuticals Market Basis Point Share Analysis, 2021 Vs. 2028

To get detailed analysis on all segments
BUY NOW

Based on Type the market is segmented as, Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other, PET Radiopharmaceuticals, F-18, RU-82, Others, Therapeutic Nuclear Medicine, Alpha Emitters, Ra-223, Brachytherapy Isotopes, Intoiodine-125, Palladium-103, Cesium-131, Iridium-192, Other brachytherapy isotopes, Beta Emitters, Intoiodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other beta emitters
Based on Application the market is segmented as, Diagnostic Applications, SPECT Applications, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications, PET applications, Oncology, Cardiology, Neurology, Other PET applications, Therapeutic Applications, Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications
Based on Procedural Volume Assessment the market is segmented as, Diagnostic Procedures, Therapeutic Procedures
Based on Source the market is segmented as, Nuclear Reactors, Cyclotrons
Based on End User the market is segmented as, Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others
Based on Regional the market is segmented as, North America, Europe, Asia Pacific, Latin America

Radiopharmaceuticals Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for Radiopharmaceuticals was estimated to be valued at US$ XX Mn in 2021.

The global Radiopharmaceuticals Market is estimated to grow at a CAGR of XX% by 2028.

The global Radiopharmaceuticals Market is segmented on the basis of Type, Application, Procedural Volume Assessment, Source, End User, Regional.

Based on region, the global Radiopharmaceuticals Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global Radiopharmaceuticals Market are Cardinal Health Inc., GE Healthcare, IBA Group, Lantheus Medical Imaging, Covidien Plc, Positron Corporation, NTP Radioisotopes Pty Ltd.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Segmentation Analysis:

Radiopharmaceuticals Market Report Snapshots

Want to customize this report?

FAQs

What is the estimated value of the global Radiopharmaceuticals Market?

What is the expected growth rate of the global Radiopharmaceuticals Market during the forecast period?

What are the key industry segments covered in the report?

On the basis of region, how is the global Radiopharmaceuticals Market segmented?

Who are the key players competing in the global Radiopharmaceuticals Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300